Introduction
============

Diabetes mellitus (DM) is considered a cardiovascular risk factor, and the rate of cardiac events in people with diabetes is 2 to 3 fold higher compared with that in patients without DM.^\[[@R1]--[@R4]\]^ Several investigations have indicated that DM patients without a history of cardiovascular events have a similar chance for myocardial infarction as compared to non-DM patients with previous coronary events.^\[[@R1]--[@R4]\]^

Coronary artery calcium (CAC) is a valuable method to assess coronary heart disease risk in diabetic patients.^\[[@R5],[@R6]\]^ However, little is known with insight into fully quantified plaque in patients with DM. Recent advancement in noninvasive computed tomography (CT)-based plaque imaging makes it possible to classify atherosclerotic plaque components and to quantify plaque volume.

There are few large cohort studies to fully quantified plaque component and volume in patients with DM.

Methods
=======

Ethical approval
----------------

The study was approved by the Ethics Committee of Fu Wai Hospital, and all patients provided informed consent for inclusion in the registry.

Patient population
------------------

We recruited 6676 consecutive patients referred for coronary CT angiography (CCTA) by their cardiologists between October 2016 and November 2017. Exclusion criteria were for the subjects who had insufficient clinical data (*n* = 212), non-diagnostic coronary images (*n* = 45), had an acute coronary syndrome (*n* = 38). Data of 6381 patients were collected for final analysis \[Figure [1](#F1){ref-type="fig"}\] and were divided into two groups (*n* = 931 patients with DM; *n* = 5450 without DM) according to the American Diabetes Association criteria.^\[[@R7]\]^

![Flow chart of this cohort study recruiting 6676 consecutive patients who underwent coronary computed tomography angiography (CCTA). DM: Diabetes mellitus](cm9-133-773-g001){#F1}

CCTA scanning and image analysis
--------------------------------

First, patients underwent non-enhanced scan to measure the calcium score. CCTA was performed, thereafter, using prospective electrocardiogram (ECG) gating. A double-head power injector was used to inject contrast media. The scanning parameters were as follows: 0.6 mm individual detector width; 280 ms gantry rotation time; 0.20 to 0.50 pitch; 200 to 250 mm field of view for raw image reconstruction. All the scans were analyzed on the workstation (ADW4.6, GE Healthcare, Milwaukee, WI, USA) by two radiologists. Calcium was defined as the presence of at least three pixels with a density of \>130 HU. The coronary artery tree was segmented according to the modified American Heart Association classification. We classified coronary plaques by calcified and non-calcified components and quantified their volumes automatically according to Hounsfield unit thresholds.^\[[@R8],[@R9]\]^ Non-calcified plaque volume was further split by lipid and fibrous plaque volumes. Total plaque was summed up by different component plaque volume.

Clinical data
-------------

Obesity was defined as body mass index (BMI) greater than 30 kg/m^2^. Hypertension was defined as systolic blood pressure \>140 mmHg, diastolic blood pressure \>90 mmHg, or antihypertensive medication use. Hypercholesterolemia was defined according to the National Cholesterol Education Program (NCEP) guidelines.^\[[@R10]\]^ A family history of coronary heart disease was defined as a history of early coronary heart disease in the immediate family (father \<55 years or mother \<65 years).

Statistical analysis
--------------------

Mann-Whitney *U* test and Chi-square test were used to compare risk factors and different quantitative plaque component volumes between the nondiabetic and diabetic patients. Chi-square test was applied to compare the prevalence of plaque in different patients. Logistic regression was used to evaluate the association between diabetes and the prevalence of plaque. Statistical analyses were performed with SPSS version 19.0 (SPSS® Inc., Chicago, IL, USA).

Results
=======

Overall, data of 6381 patients (3351 men and 3030 women) were collected for the final analysis, including 931 (14.59%) patients with DM, and 5450 (85.41%) without DM \[Table [1](#T1){ref-type="table"}\]. The traditional cardiovascular risk factors were more pronounced in DM patients as compared to the non-DM patients except for presence of family history.

###### 

Baseline characteristics of all the 6381 consecutive patients underwent coronary computed tomography angiography.

![](cm9-133-773-g002)

In Table [2](#T2){ref-type="table"}, 2249 (35.25%) patients (450 DM patients and 1799 nondiabetic patients) had plaque detected on CCTA. The prevalence of plaque was significantly higher in DM subjects compared with nondiabetic group (lipid: 47.37% *vs.* 32.22%, fibrous: 48.23% *vs.* 33.00%, calcified: 37.92% *vs.* 24.97%, respectively, *P* \< 0.001). Moreover, the prevalence of non-calcified plaque was significantly higher in the DM subjects (48.34% *vs.* 33.01%, *P* \< 0.001) \[Table [2](#T2){ref-type="table"}, Figure [2](#F2){ref-type="fig"}\]. In the univariate analysis, DM was a risk factor for plaque. DM remained an independent risk factor of the presence of plaques in a multivariate model (OR = 1.465, 95% CI: 1.258--1.706, *P* \< 0.001) \[Table [3](#T3){ref-type="table"})\].

###### 

The prevalence of plaque in patients with and without DM, *n* (%).
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![Maximum intensity projection (A) showed a mixed plaque (arrow) in the proximal anterior descending branch (LAD), volume rendering (B) showed the plaque caused more than 50% stenosis (arrow) in a 59-year-old female patient with diabetes mellitus (height: 1.60 m, weight: 60 kg).](cm9-133-773-g004){#F2}

###### 

Logistic regression analysis between DM and the prevalence of plaque.
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Plaque volumes ranged from 0 to 371.1 mm^3^ (inter quartile range (IQR): 8.9 mm^3^) in lipid plaques, from 0 to 2286.0 mm^3^ (IQR: 92.0 mm^3^) in fibrous plaques, and from 0 to 326.4 mm^3^(IQR: 0.5 mm^3^) in calcified plaques, respectively. The mean plaque volumes for lipid, fibrous and calcified plaques were significantly higher in the DM subjects than those in the nondiabetic patients (lipid plaques: IQR: 25.2 mm^3^*vs.* 6.3 mm^3^, *P* \< 0.001; fibrous plaques: IQR: 171.7 mm^3^*vs.* 73.0 mm^3^, *P* \< 0.001; calcified plaques: IQR: 5.3 mm^3^*vs.* 0.1 mm^3^, *P* \< 0.001). Similar findings between the DM and non-DM groups were also observed for non-calcified and total plaque volume (IQR: 210.2 mm^3^*vs.* 85.6 mm^3^, *P* \< 0.001; 222.2 mm^3^*vs.* 91.8mm^3^, *P* \< 0.001) \[Figure [3](#F3){ref-type="fig"}, Table [4](#T4){ref-type="table"}\].

![The quantified plaque volume in patients with and without DM. The lipid plaque volume (A), fibrous plaque volume (B), calcified plaque volume (C), non-calcified (D) and total plaque volume (E) in diabetic subjects were significantly greater than non-diabetic patients (*P* \< 0.001). DM: Diabetes mellitus.](cm9-133-773-g006){#F3}

###### 

The quantified plaque component and volume in patients with and without DM.
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Discussion
==========

In this cross-sectional study, we found significant higher prevalence of coronary plaques and consistently higher plaque volumes of all the detected compositions among the patients with DM as compared to those without DM, which was consistent with previous studies.^\[[@R11],[@R12]\]^

Although prior studies have rejected the theory of equivalency of diabetes with CAD,^\[[@R13]\]^ the harm that diabetes does to cardiovascular system still cannot ignore.^\[[@R14],[@R15]\]^ The calcification score is only a quantification of calcified plaques, but in diabetic patients, there are a large number of non-calcified plaques in coronary arteries.^\[[@R16]\]^ It has been shown that overall coronary plaque burden is a better predictor of future cardiovascular events.^\[[@R17]\]^ In the past, the quantitative analysis of coronary artery plaque mainly relied on intravascular Ultrasound (IVUS).^\[[@R18]\]^ Compared to IVUS, CT is also good at quantifying plaque, and can be used to study large populations.^\[[@R19]\]^

We found the prevalence of any plaque in DM subjects was remarkably high (48.34%), and DM was an independent risk factor. Pundziute *et al*^\[[@R20]\]^ demonstrated in patients with diabetes, the segment of coronary artery plaque increased significantly. In a postmortem study, Burke *et al*^\[[@R21]\]^ showed that patients with DM have a larger total and distal plaque.

Previous study had also looked at the components of coronary plaque in patients with DM.^\[[@R22]\]^ We found significantly greater calcified plaque volume in the DM patients than in the nondiabetic patients. As shown in a recent meta-analysis study of symptomatic patients without known CAD, calcifications assessed through CT scans are more frequent in patients with DM.^\[[@R23]\]^ Similarly, patients with diabetes were also found to have a higher calcified plaque burden in their coronary arteries by the Multi-Ethnic Study of Atherosclerosis (MESA).^\[[@R24]\]^ Previous study had also found a significant increase in the necrotic core and inflammatory cells of coronary plaque in diabetic patients.^\[[@R25]--[@R28]\]^ Such plaque was vulnerable plaque that could lead to acute events. In this study, we also found the volumes of lipid plaque and fibrous plaque was significantly higher in DM patients.

Study limitations
-----------------

High-risk characteristics in the diabetic population may be partially influenced by daily glucose fluctuation and may be found already in patients with an impaired glucose tolerance.^\[[@R29]\]^ However, in our study, we cannot fully exclude impaired glucose tolerance without overt diabetes mellitus in our non-DM group as oral glucose tolerance testing was not performed routinely. An autopsy study demonstrated an association between DM duration and the extent of atherosclerosis and myocardial lesions,^\[[@R30]\]^ so the duration of DM should be considered in the future studies.

In conclusion, the coronary artery atherosclerotic plaques were significantly higher in diabetic patients than those in non-diabetic patients.
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